marijuana stocks news

Cara Therapeutics to Webcast Presentation at 17th Annual BIO CEO & Investor Conference

SHELTON, Conn., Feb. 2, 2015 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015, at 8:30 a.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200
Jesse@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published.

You May Also Like

$MNZO Announces Plans for Human Clinical Studies

Manzo Pharmaceuticals Announces Plans for Human Clinical Studies of the Company’s Patented…

Trulieve Cannabis Corp. (TCNNF) to Begin Adult-Use Cannabis Sales at Relocated Bristol, CT Dispensary

Trulieve to Begin Adult-Use Cannabis Sales at Relocated Bristol, CT Dispensary Trulieve…

HEXO Corp (HEXO) to Release Fiscal Second Quarter 2021 Financial Results and Host Investor Webcast

HEXO Corp to Release Fiscal Second Quarter 2021 Financial Results and Host…

Sundial Growers Inc. (SNDL) Announces 2020 Launch of Medical Cannabis Marketplace

Sundial Announces 2020 Launch of Medical Cannabis Marketplace Sundial Growers Inc. (Nasdaq:…